Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-06-15

Clinical Trial Results: A Study to Evaluate the Reduction in Sebum (Skin Oil) Induced by Clascoterone Cream 1% in Acne Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating clascoterone 1% cream and its effect on reducing skin oil in acne patients; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clascoterone cream 1% (clascoterone)

Snippet

Sponsor: Sun Pharmaceutical Industries Limited | Conditions: Acne Vulgaris | Phase 4 | Status: COMPLETED | Results posted: 2026-06-15